TOKYO (Kyodo) -- A urine-based cancer risk screening kit developed by a Japanese startup is showing promise in detecting cancer at the earliest stage ...

Standard BioTools announces the strategic sale of SomaLogic to Illumina for up to $425 million, simplifying operations.

A urine-based cancer risk screening kit developed by a Japanese startup is showing promise in detecting cancer at the earliest stage using non-invasive means. The test kit from Craif Inc, a spin-off ...

Standard BioTools (NASDAQ:LAB) shares jumped as much as 19% premarket on Monday after the company announced the sale of its SomaLogic business to Illumina (NASDAQ:ILMN) for an aggregate cash ...

The kit utilizes Illumina-compatible adapter sequences and has been validated on Illumina platforms. Main Features Input as low as 60 fresh cells (400 pg DNA). Around 100-300 FFPE cells (660-1980 pg).

A urine-based cancer risk screening kit developed by a Japanese startup is showing promise in detecting cancer at the earliest stage using non-invasive means. The test kit from Craif Inc., a spin ...

The Milwaukee M18 Lithium-Ion XC 5.0Ah Battery & Charger Starter Kit is just $90 at Walmart. Shoppers say it’s very "convenient" and “built for the long haul.” ...

Mark Zuckerberg’s Meta, hell-bent on expanding its artificial intelligence capabilities, just invested $14.3 billion in Scale AI, acquiring a 49 percent stake in the San Francisco-based startup ...

TOKYO, June 22 (Bernama-Kyodo) -- A urine-based cancer risk screening kit developed by a Japanese startup is showing promise in detecting cancer at the earliest stage using non-invasive means, Kyodo ...